Marek Svoboda

6.3k total citations · 1 hit paper
139 papers, 5.1k citations indexed

About

Marek Svoboda is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Marek Svoboda has authored 139 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 69 papers in Molecular Biology and 42 papers in Oncology. Recurrent topics in Marek Svoboda's work include MicroRNA in disease regulation (46 papers), Cancer-related molecular mechanisms research (44 papers) and Circular RNAs in diseases (33 papers). Marek Svoboda is often cited by papers focused on MicroRNA in disease regulation (46 papers), Cancer-related molecular mechanisms research (44 papers) and Circular RNAs in diseases (33 papers). Marek Svoboda collaborates with scholars based in Czechia, Austria and United States. Marek Svoboda's co-authors include Ondřej Slabý, Rostislav Vyzula, Pavel Fabián, Lenka Radová, Jiří Šáňa, Alexandr Poprach, Petra Faltejsková, Radek Lakomý, Jaroslav Michálek and Rudolf Nenutil and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marek Svoboda

131 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

2007 589 citations Ondřej Slabý, Marek Svoboda et al. profile →

Peers

Marek Svoboda

ONCOL

PRM

SURGE

Keun Hur South Korea

Nozomu Yanaihara Japan

Gerald W. Verhaegh Netherlands

Xinhua Xie China

Seema Sethi United States

Yin Sun China

Cátia Moutinho Spain

Lenka Radová Czechia

Shanliang Zhong China

Bríd M. Ryan United States

Keun Hur South Korea

Marek Svoboda

3.3k ×0.8

2.8k ×0.8

668 ×0.9

ONCOL

424 ×0.7

PRM

414 ×1.1

SURGE

Citations per year, relative to Marek Svoboda Marek Svoboda (= 1×) peers Keun Hur

Countries citing papers authored by Marek Svoboda

Since Specialization

Citations

This map shows the geographic impact of Marek Svoboda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Svoboda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Svoboda more than expected).

Fields of papers citing papers by Marek Svoboda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Svoboda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Svoboda. The network helps show where Marek Svoboda may publish in the future.

Co-authorship network of co-authors of Marek Svoboda

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Svoboda. A scholar is included among the top collaborators of Marek Svoboda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Svoboda. Marek Svoboda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Selingerová, Iveta, Tomáš Kazda, Alexandr Poprach, et al.. (2024). Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018–2022. Klinicka onkologie. 37(6). 433–444.

Poprach, Alexandr, Igor Kišš, Michal Staník, et al.. (2023). Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma. Targeted Oncology. 18(6). 893–903. 3 indexed citations

Prades, Joan, Annalisa Trama, Paolo G. Casali, et al.. (2022). Is rare cancer care organized at national health system level? Multiple case study in six EU countries. European Journal of Public Health. 32(6). 852–857. 2 indexed citations

Musilová, Petra, et al.. (2022). Chromosomal damage in occupationally exposed health professionals assessed by two cytogenetic methods. Archives of Environmental & Occupational Health. 78(3). 158–169. 1 indexed citations

Büchler, Tomáš, Alexandr Poprach, Ondřej Fiala, et al.. (2018). Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis. Cancer Management and Research. Volume 11. 359–368. 8 indexed citations

Fiala, Ondřej, Veronika Veškrňová, Alexandr Poprach, et al.. (2018). Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis. Targeted Oncology. 13(6). 735–743. 5 indexed citations

Büchler, Tomáš, Alexandr Poprach, Zbyněk Bortlíček, et al.. (2017). Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer. Clinical Genitourinary Cancer. 15(6). e1047–e1053. 8 indexed citations

Lakomý, Radek, Alexandr Poprach, Zbyněk Bortlíček, et al.. (2017). Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. BMC Cancer. 17(1). 880–880. 9 indexed citations

Pichler, Martin, Verena Stiegelbauer, Petra Vychytilova‐Faltejskova, et al.. (2016). Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clinical Cancer Research. 23(5). 1323–1333. 61 indexed citations

10.

Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Poprach, Alexandr, Radek Lakomý, Zbyněk Bortlíček, et al.. (2016). Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice. Drugs & Aging. 33(9). 655–663. 15 indexed citations

12.

Němeček, Radim, Lenka Radová, Tomáš Kazda, et al.. (2016). Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy. OncoTargets and Therapy. Volume 9. 4695–4703. 15 indexed citations

13.

Poprach, Alexandr, Zbyněk Bortlíček, Bohuslav Melichar, et al.. (2015). Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency. European Journal of Cancer. 51(4). 507–513. 10 indexed citations

14.

Dušek, Ladislav, Jan Mužı́k, Tomáš Pavlík, et al.. (2014). Cancer Incidence and Mortality in the Czech Republic. Klinicka onkologie. 27(6). 406–423. 38 indexed citations

15.

Svoboda, Marek, Jiří Šáňa, Martina Rédová, et al.. (2012). MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagnostic Pathology. 7(1). 31–31. 52 indexed citations

16.

Fabián, Pavel, Lenka Radová, Ondřej Slabý, et al.. (2012). Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. International Journal of Oncology. 41(4). 1204–1212. 19 indexed citations

17.

Lakomý, Radek, Pavel Fadrus, Pavel Šlampa, et al.. (2011). Výsledky multimodální léčby glioblastoma multiforme:konsekutivní série 86 pacientů diagnostikovaných v letech2003–2009. Klinicka onkologie. 24(2). 1 indexed citations

18.

Slabý, Ondřej, Roman Hrstka, Lenka Zdražilová Dubská, et al.. (2008). Significance of microRNA-21 in colorectal cancer pathogenesis.. FEBS Journal. 275. 465–465. 1 indexed citations

19.

Svoboda, Marek, Pavel Fabián, Markéta Palácová, et al.. (2007). Brain metastases in breast cancer: a retrospective cohort studyof 187 patients and prognostic markers determination.. Breast Cancer Research and Treatment. 106. 1 indexed citations

20.

Svoboda, Marek, J Vyskočil, & Jana Nováková. (2006). Statiny v onkologii. 19(3). 155–159. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact